Chapter
Funding for Aging Research vs. Cancer Research
1:18:58 - 1:24:08 (05:09)
The research on aging has been matured in the last two decades to the point where it should be funded equally with cancer research which has been getting funding for the last 50 years. Aging research should not be made fun of because it is merely behind cancer research by 50 years.
Clips
Despite the fact that cancer research is being funded with about $6 billion annually, research in biology of aging (which receives only $350 million in annual funding) has not been receiving enough attention and funding from billionaires even though many of them express eagerness to live longer.
1:18:58 - 1:19:39 (00:40)
Summary
Despite the fact that cancer research is being funded with about $6 billion annually, research in biology of aging (which receives only $350 million in annual funding) has not been receiving enough attention and funding from billionaires even though many of them express eagerness to live longer.
ChapterFunding for Aging Research vs. Cancer Research
Episode#610: The Life-Extension Episode — Dr. Matt Kaeberlein on The Dog Aging Project, Rapamycin, Metformin, Spermidine, NAD+ Precursors, Urolithin A, Acarbose, and Much More
PodcastThe Tim Ferriss Show
The speaker suggests looking at the impact on life expectancy for a typical 50-year-old woman when curing cancer.
1:19:39 - 1:21:23 (01:44)
Summary
The speaker suggests looking at the impact on life expectancy for a typical 50-year-old woman when curing cancer. Cancer was once the second leading cause of death in the US and only in the last two decades, research in the field has matured to the point where it deserves the funding it has been getting for the past 50 years.
ChapterFunding for Aging Research vs. Cancer Research
Episode#610: The Life-Extension Episode — Dr. Matt Kaeberlein on The Dog Aging Project, Rapamycin, Metformin, Spermidine, NAD+ Precursors, Urolithin A, Acarbose, and Much More
PodcastThe Tim Ferriss Show
Targeting the root biology of disease has the potential to increase lifespan more effectively than a disease-first approach, which only addresses a single condition.
1:21:23 - 1:24:08 (02:45)
Summary
Targeting the root biology of disease has the potential to increase lifespan more effectively than a disease-first approach, which only addresses a single condition.